The overarching goal of this project is to optimize the PrEP Choice integrated mHealth package and assess the efficacy and cost of PrEP Choice on PrEP initiation and adherence among young people. It is hypothesized that PrEP Choice will improve HIV PrEP uptake and adherence among young people and will be cost-effective to deliver to young people in the United States (U.S.). This study will also assess the uptake, adherence, and acceptability of DoxyPEP among young people.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
PrEP Uptake; proportion of participants receiving PrEP from the study site within 9 months of study follow-up
Timeframe: first 9 months of follow up
PrEP Adherence; rate at which participants who received PrEP on study adhere to selected PrEP regimen as measured by dried blood spot for oral regimen and by the on-time CAB-LA and LEN injections for injectable PrEP
Timeframe: first 9 months of follow-up
DoxyPEP Uptake; the rate at which participants receive DoxyPEP from the study site
Timeframe: 18 months of follow up
DoxyPEP Adherence; the rate at which participants are adherent to DoxyPEP coverage of condomless sexual exposures as measured by self-report
Timeframe: 18 months of follow up
DoxyPEP Acceptability; assessed by Likert scale every 3 months of study follow-up
Timeframe: 18 months of follow up